FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2267513873> ?p ?o ?g. }

• W2267513873 abstract "Objective The sodium-glucose cotransporter 2 (SGLT-2) inhibitors are an important addition to available treatments for patients with type 2 diabetes (T2D) as an adjunct to modifications in diet and exercise. SGLT-2 inhibitors may be prescribed alone or as add-on treatment in patients receiving metformin, sulfonylureas, thiazolidinediones, dipeptidyl peptidase-4 inhibitors, and/or insulin across the natural history of the disease. Inhibition of SGLT-2, which is responsible for approximately 90% of renal glucose reabsorption, increases urinary glucose excretion and lowers blood glucose concentrations. The objective of this review is to discuss the pathophysiology of diabetes and the contribution of the kidney to glucose homeostasis and to provide an evidence-based practice approach to clinical applications of SGLT-2 inhibitors in the treatment of T2D. Methods PubMed and Google Scholar databases were searched to identify literature published from 1990 through September 2015 examining the pathophysiology of T2D, the role of the kidney in regulating glucose concentrations, and clinical evidence for the efficacy and safety of SGLT-2 inhibitors in T2D. Results There is a need for early treatment in patients with T2D to minimize the risk of cardiovascular complications that increase morbidity and mortality. SGLT-2 inhibitors improve glycemic control, reduce body weight and blood pressure, and are associated with a low risk of hypoglycemia. Adverse events associated with SGLT-2 inhibitors include mild to moderate urinary tract and genital infections and mild dehydration potentially leading to orthostatic hypotension. Conclusions An evidence-based practice approach to examining the importance of early, proactive treatment of T2D using SGLT-2 inhibitors from initiation of pharmacotherapy to increasingly more complicated combination therapy regimens, including insulin, suggests that this treatment strategy maximizes benefits and minimizes potential side effects. The SGLT-2 inhibitors augment the arsenal of available antidiabetes agents, facilitating the ability of clinicians to design tailored treatment regimens that help patients achieve therapeutic goals." @default.
• W2267513873 created "2016-06-24" @default.
• W2267513873 creator A5007452437 @default.
• W2267513873 creator A5035160880 @default.
• W2267513873 date "2016-02-26" @default.
• W2267513873 modified "2023-09-24" @default.
• W2267513873 title "Sodium–glucose cotransporter 2 inhibitors: an evidence-based practice approach to their use in the natural history of type 2 diabetes" @default.
• W2267513873 cites W1610463472 @default.
• W2267513873 cites W162195211 @default.
• W2267513873 cites W1834962231 @default.
• W2267513873 cites W1953840628 @default.
• W2267513873 cites W1955935325 @default.
• W2267513873 cites W1967064223 @default.
• W2267513873 cites W1970573278 @default.
• W2267513873 cites W1973240292 @default.
• W2267513873 cites W1982293047 @default.
• W2267513873 cites W1982905493 @default.
• W2267513873 cites W1987553321 @default.
• W2267513873 cites W1990025047 @default.
• W2267513873 cites W2001991301 @default.
• W2267513873 cites W2008443217 @default.
• W2267513873 cites W2008577165 @default.
• W2267513873 cites W2015191704 @default.
• W2267513873 cites W2019285763 @default.
• W2267513873 cites W2021517048 @default.
• W2267513873 cites W2021524336 @default.
• W2267513873 cites W2026412750 @default.
• W2267513873 cites W2030192134 @default.
• W2267513873 cites W2033417941 @default.
• W2267513873 cites W2038270027 @default.
• W2267513873 cites W2048260881 @default.
• W2267513873 cites W2051243940 @default.
• W2267513873 cites W2052503411 @default.
• W2267513873 cites W2056638625 @default.
• W2267513873 cites W2066981028 @default.
• W2267513873 cites W2068171948 @default.
• W2267513873 cites W2072040765 @default.
• W2267513873 cites W2074989651 @default.
• W2267513873 cites W2075627118 @default.
• W2267513873 cites W2077038286 @default.
• W2267513873 cites W2077636750 @default.
• W2267513873 cites W2081510795 @default.
• W2267513873 cites W2087539094 @default.
• W2267513873 cites W2090088543 @default.
• W2267513873 cites W2093537833 @default.
• W2267513873 cites W2098991629 @default.
• W2267513873 cites W2100796772 @default.
• W2267513873 cites W2101329765 @default.
• W2267513873 cites W2101344933 @default.
• W2267513873 cites W2101374656 @default.
• W2267513873 cites W2101865653 @default.
• W2267513873 cites W2106952837 @default.
• W2267513873 cites W2107146663 @default.
• W2267513873 cites W2107832644 @default.
• W2267513873 cites W2109728760 @default.
• W2267513873 cites W2114031829 @default.
• W2267513873 cites W2114250030 @default.
• W2267513873 cites W2114276479 @default.
• W2267513873 cites W2116210871 @default.
• W2267513873 cites W2117505171 @default.
• W2267513873 cites W2117512154 @default.
• W2267513873 cites W2118613762 @default.
• W2267513873 cites W2120922908 @default.
• W2267513873 cites W2122077393 @default.
• W2267513873 cites W2123862315 @default.
• W2267513873 cites W2123984464 @default.
• W2267513873 cites W2127413863 @default.
• W2267513873 cites W2128050336 @default.
• W2267513873 cites W2130274258 @default.
• W2267513873 cites W2130570549 @default.
• W2267513873 cites W2134652590 @default.
• W2267513873 cites W2137069992 @default.
• W2267513873 cites W2141800817 @default.
• W2267513873 cites W2146264128 @default.
• W2267513873 cites W2147076608 @default.
• W2267513873 cites W2148328779 @default.
• W2267513873 cites W2149943414 @default.
• W2267513873 cites W2150219016 @default.
• W2267513873 cites W2150855258 @default.
• W2267513873 cites W2152413054 @default.
• W2267513873 cites W2153399820 @default.
• W2267513873 cites W2154080381 @default.
• W2267513873 cites W2154279165 @default.
• W2267513873 cites W2155287847 @default.
• W2267513873 cites W2155873662 @default.
• W2267513873 cites W2157405334 @default.
• W2267513873 cites W2157891776 @default.
• W2267513873 cites W2160471487 @default.
• W2267513873 cites W2161852973 @default.
• W2267513873 cites W2162427196 @default.
• W2267513873 cites W2167245776 @default.
• W2267513873 cites W2168926920 @default.
• W2267513873 cites W2171049608 @default.
• W2267513873 cites W2171471305 @default.
• W2267513873 cites W2269288506 @default.
• W2267513873 cites W2271771390 @default.
• W2267513873 cites W2275139239 @default.
• W2267513873 cites W3036588604 @default.
• W2267513873 doi "https://doi.org/10.1185/03007995.2016.1151774" @default.
• W2267513873 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26854518" @default.

• next